Spots Global Cancer Trial Database for Safety Study for Short-course Accelerated, Hypofractionated Partial Breast Radiotherapy (APBI) in Women With Early Stage Breast Cancer Using the Contura MLB
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Safety Study for Short-course Accelerated, Hypofractionated Partial Breast Radiotherapy (APBI) in Women With Early Stage Breast Cancer Using the Contura MLB
Official Title: Safety and Feasibility of Short-Course, Accelerated, Hypofractionated Partial Breast Radiotherapy in Women With Early Stage Breast Cancer Using the Contura MLB Breast Brachytherapy Catheter: A Phase II Trial
Study ID: NCT01072838
Conditions
Study Description
Brief Summary: To determine local disease control (recurrence) with shorter course of APBI delivered with a breast brachytherapy applicator.
Detailed Description:
Eligibility
Minimum Age: 50 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
William Beaumont Hospital, Royal Oak, Michigan, United States
Cancer Institute of New Jersey, New Brunswick, New Jersey, United States
Virginia Commonwealth University, Richmond, Virginia, United States
Contact Details
Name: Atif Khan, MD
Affiliation: Rutgers Cancer Institute of New Jersey
Role: PRINCIPAL_INVESTIGATOR
Name: Douglas W. Arthur, MD
Affiliation: Virginia Commonwealth University
Role: PRINCIPAL_INVESTIGATOR
Name: Mihai Ghilezan, MD
Affiliation: William Beaumont Hospitals
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
